Natus Medical Inc
NASDAQ:NTUS
Natus Medical Inc
Operating Income
Natus Medical Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Natus Medical Inc
NASDAQ:NTUS
|
Operating Income
$29.4m
|
CAGR 3-Years
33%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Natus Medical Inc's Operating Income?
Operating Income
29.4m
USD
Based on the financial report for Dec 31, 2021, Natus Medical Inc's Operating Income amounts to 29.4m USD.
What is Natus Medical Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-12%
The average annual Operating Income growth rates for Natus Medical Inc have been 33% over the past three years , -12% over the past five years .